Impact of Abiraterone Evident in New AUA Guidelines for mCRPC
August 15th 2013Amid a flurry of new drug approvals, the AUA has issued its first set of guidelines for the management of patients with mCRPC, which included an extensive role for abiraterone acetate at several stages of the disease.
More Than 200 Agents in Blood Cancer Pipeline
August 9th 2013The biopharmaceutical industry has 241 medicines in development for the treatment of leukemia, lymphoma, myeloma, and other blood cancers, which together are expected to comprise 9%, or 150,000, of new oncologic diagnoses in America this year.
Cryoablation May Offer Option for Metastatic Lung Tumors
August 1st 2013The results of the first prospective multicenter trial of cryoablation in lung cancer show that this emerging treatment may be a safe, effective, and minimally invasive method of helping a specific group of patients with advanced disease.
A Failure to Communicate: Patients Misunderstand Cancer Genetic Testing
July 30th 2013Patients diagnosed with cancer today are considered to be genuine partners in all major treatment decisions. Yet, how well do they understand the nature and goals of genetic testing that might be recommended as part of the management of their disease?